The goal of this series is for all head and neck surgery physicians to be aware and implement current evidence-based medicine treatment recommendations and guidelines into their busy practice. In addition, head and neck surgeons should be aware of new technologies that are coming into market that have shown benefit based on the literature.
Target Audience: Head and Neck Surgeons
Series Objectives: Upon completion of this activity, participants should be able to:
- Implement new practice guidelines or treatment recommendations based on the current literature.
- Apply treatment algorithms for complex diagnoses based on latest evidence.
- Further the practice of evidence based medicine.
Location: South San Francisco: Head and Neck Surgery office
- Traboulsi H, Alam E, Hadi U. Changing Trends in the Management of Epistaxis. Int J Otolaryngol. 2015;2015:263987. doi: 10.1155/2015/263987. Epub 2015 Aug 16.
- Reyre A, Michel J, Santini L, Dessi P, Vidal V, Bartoli JM, Moulin G, Varoquaux A. Epistaxis: The role of arterial embolization. Diagn Interv Imaging. 2015 Jul‐Aug;96(7‐8):757‐73. doi: 10.1016/j.diii.2015.06.006. Epub 2015 Jul 17.
- Lin G, Bleier B. Surgical Management of Severe Epistaxis. Otolaryngol Clin North Am. 2016 Jun;49(3):627‐37. doi: 10.1016/j.otc.2016.01.003.
- Leung RM, Smith TL, Rudmik L.. Developing a laddered algorithm for the management of intractable epistaxis: a risk analysis. JAMA Otolaryngol Head Neck Surg. 2015 May 1;141(5):405‐9. doi: 10.1001/jamaoto.2015.106.
- Rudmik L, Leung R. Cost‐effectiveness analysis of endoscopic sphenopalatine artery ligation vs arterial embolization for intractable epistaxis. JAMA Otolaryngol Head Neck Surg. 2014 Sep;140(9):802‐8. doi: 10.1001/jamaoto.2014.1450.
- Cocaine induced midline destructive lesions. Trimarchi M, Bertazzoni G, Bussi M. Rhinology. 2014 Jun;52(2):104-11. doi: 10.4193/Rhin.
- The dilemma of midline destructive lesions: a case series and diagnostic review. Parker NP, Pearlman AN, Conley DB, Kern RC, Chandra RK. Am J Otolaryngol. 2010 Mar-Apr;31(2):104-9. doi: 10.1016/j.amjoto.2008.11.010. Epub 2009 Mar 27.
- Idiopathic midline destructive disease: fact or fiction. Rodrigo JP, Suárez C, Rinaldo A, Devaney KO, Carbone A, Barnes L, Heffner DK, Ferlito A. Oral Oncol. 2005 Apr;41(4):340-8.
- CIMDL 2014.pdf
Adriane Concus, MD
Christian Conderman, MD
Ramona Fung, MD
Wendy M Smith, MD
Darshni Vira, MD
Department of Head and Neck Surgery
Jie Zheng, MD
Chief of Medical Education
Eleanor Becker, MD
Former Chief of Medical Education
Tenisha Jones, MLIS
Disclosure: Kaiser Permanente South San Francisco has determined that the speakers and the planning committee for this activity do not have any relevant financial relationships. Kaiser Permanente South San Francisco takes responsibility for the content quality and scientific integrity of this CME Activity.
Kaiser Permanente does not endorse any brand-name products.
The Kaiser Permanente South San Francisco designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Kaiser Permanente South San Francisco is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians.